PINK news

Simplify Health Care · Healthcare · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
14.8% of PINK
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
12.7% of PINK
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
15.9% of PINK
www.theepochtimes.com · 28 Oct 2026, 00:00 UTC
Judge Declines to Block Eli Lilly Weight-Loss Drug Ads in Dispute With Novo Nordisk
12.7% of PINK
Where to buy PINK
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Quartz · 28 Oct 2026, 12:37 UTC
10 Medicare Advantage insurer ratings for 2027 across 4 categories
8.5% of PINK
Seeking Alpha · 27 Oct 2026, 22:08 UTC
Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top Pick (NVO) | Seeking Alpha
12.7% of PINK
Where to buy PINK
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Quartz · 28 Oct 2026, 17:20 UTC
Lilly's retatrutide more than doubled Ozempic weight loss in trial
6.8% of PINK
24/7 Wall St. · 28 Oct 2026, 19:24 UTC
16% of Employers Are Thinking About Cutting Weight-Loss Drug Coverage
5.9% of PINK
Market Screener · 28 Oct 2026, 12:21 UTC
United Therapeutics Corporation Receives FDA Clearance To Proceed With Clinical Trial For Treprostinil-Iloprost SMI In Pulmonary Arterial Hypertension
6.9% of PINK
RTTNews · 28 Oct 2026, 11:38 UTC
United Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH Therapy
6.9% of PINK
Investing.com · 28 Oct 2026, 11:12 UTC
United Therapeutics gets FDA nod for PAH combination therapy trial By Investing.com
6.9% of PINK
wallstreet:online · 28 Oct 2026, 11:05 UTC
United Therapeutics Announces FDA Clearance to Proceed with Clinical Trial for Treprostinil-Iloprost SMI in Pulmonary Arterial Hypertension
6.9% of PINK
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
5.9% of PINK
Yahoo! Finance · 27 Oct 2026, 15:16 UTC
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
11.4% of PINK
Quartz · 27 Oct 2026, 11:29 UTC
Judge rejects Novo Nordisk bid to block Eli Lilly weight-loss ads
12.7% of PINK
Benzinga · 28 Oct 2026, 13:25 UTC
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic's Weight Loss in Late-Stage Diabetes Trial -
5.9% of PINK
Benzinga · 27 Oct 2026, 10:51 UTC
Novo Nordisk Loses Court Bid Against Eli Lilly's Weight-Loss Drug Ads -- Judge Says Sales Impact Was Negli
12.7% of PINK
Seeking Alpha · 28 Oct 2026, 13:49 UTC
UnitedHealth: Raised Premiums, Market Exits And Member Attrition Deliver Future Resilience | Seeking Alpha
5.8% of PINK
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
5.9% of PINK
Market Screener · 28 Oct 2026, 12:07 UTC
Eli Lilly And Company Announces Positive Topline Results From TRANSCEND-T2D-2 Phase 3 Trial Of Retatrutide In Adults With Type 2 Diabetes
5.9% of PINK

PINK news

Where to buy PINK

Where to buy PINK